101 related articles for article (PubMed ID: 7511988)
1. QT prolongation and possibility of ventricular arrhythmias after intracoronary papaverine.
Inoue T; Asahi S; Takayanagi K; Morooka S; Takabatake Y
Cardiology; 1994; 84(1):9-13. PubMed ID: 7511988
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the risk factors for ventricular arrhythmias secondary to QT prolongation induced by papaverine injection during coronary flow reserve studies using a 4 Fr angio-catheter.
Okabe Y; Otowa K; Mitamura Y; Murai H; Usui S; Kaneko S; Takamura M
Heart Vessels; 2018 Nov; 33(11):1358-1364. PubMed ID: 29713819
[TBL] [Abstract][Full Text] [Related]
3. Torsades de pointes after intracoronary papaverine.
Vrolix M; Piessens J; De Geest H
Eur Heart J; 1991 Feb; 12(2):273-6. PubMed ID: 2044564
[TBL] [Abstract][Full Text] [Related]
4. Ventricular arrhythmia due to intracoronary papaverine: analysis of QT intervals and coronary vasodilatory reserve.
Kern MJ; Deligonul U; Serota H; Gudipati C; Buckingham T
Cathet Cardiovasc Diagn; 1990 Apr; 19(4):229-36. PubMed ID: 2334953
[TBL] [Abstract][Full Text] [Related]
5. Intracoronary electrocardiogram during torsade des pointes secondary to intracoronary papaverine.
Jain A; Jenkins MG
Cathet Cardiovasc Diagn; 1989 Dec; 18(4):255-7. PubMed ID: 2605630
[TBL] [Abstract][Full Text] [Related]
6. Intravenous adenosine: continuous infusion and low dose bolus administration for determination of coronary vasodilator reserve in patients with and without coronary artery disease.
Kern MJ; Deligonul U; Tatineni S; Serota H; Aguirre F; Hilton TC
J Am Coll Cardiol; 1991 Sep; 18(3):718-29. PubMed ID: 1869735
[TBL] [Abstract][Full Text] [Related]
7. Papaverine-induced QT interval prolongation and ventricular fibrillation in a patient with a history of drug-induced QT prolongation.
Goto M; Sato M; Kitazawa H; Takahashi M; Fuse K; Saito A; Okabe M; Aizawa Y
Intern Med; 2014; 53(15):1629-31. PubMed ID: 25088875
[TBL] [Abstract][Full Text] [Related]
8. Papaverine-induced polymorphic ventricular tachycardia during coronary flow reserve study of patients with moderate coronary artery disease.
Nakayama M; Tanaka N; Sakoda K; Hokama Y; Hoshino K; Kimura Y; Ogawa M; Yamashita J; Kobori Y; Uchiyama T; Aizawa Y; Yamashina A
Circ J; 2015; 79(3):530-6. PubMed ID: 25746536
[TBL] [Abstract][Full Text] [Related]
9. Polymorphous ventricular tachycardia: a side effect of intracoronary papaverine.
Talman CL; Winniford MD; Rossen JD; Simonetti I; Kienzle MG; Marcus ML
J Am Coll Cardiol; 1990 Feb; 15(2):275-8. PubMed ID: 2299067
[TBL] [Abstract][Full Text] [Related]
10. Probucol-induced QT prolongation and torsades de pointes.
Matsuhashi H; Onodera S; Kawamura Y; Hasebe N; Kohmura C; Yamashita H; Tobise K
Jpn J Med; 1989; 28(5):612-5. PubMed ID: 2585889
[TBL] [Abstract][Full Text] [Related]
11. Coronary flow reserve in patients with dilated cardiomyopathy.
Inoue T; Sakai Y; Morooka S; Hayashi T; Takayanagi K; Yamanaka T; Kakoi H; Takabatake Y
Am Heart J; 1993 Jan; 125(1):93-8. PubMed ID: 8417548
[TBL] [Abstract][Full Text] [Related]
12. Vasodilatory capacity of coronary resistance vessels in dilated cardiomyopathy.
Inoue T; Sakai Y; Morooka S; Hayashi T; Takayanagi K; Yamaguchi H; Kakoi H; Takabatake Y
Am Heart J; 1994 Feb; 127(2):376-81. PubMed ID: 8296706
[TBL] [Abstract][Full Text] [Related]
13. [Coronary reserve determination by intracoronary papaverine: effects of various doses on coronary circulation and hemodynamics].
Franz N; Modersohn D; Romaniuk P; Linss G
Z Gesamte Inn Med; 1991; 46(1-2):15-7. PubMed ID: 2038868
[TBL] [Abstract][Full Text] [Related]
14. [Ventricular tachyarrhythmia induced by low doses of sotalol: torsade de pointes or polymorphous ventricular tachycardia?].
Ophoff N; Toker Y
Z Kardiol; 1988 Jun; 77(6):393-7. PubMed ID: 3213144
[TBL] [Abstract][Full Text] [Related]
15. [Inverse relationship between coronary flow velocity and myocardial oxygen extraction during intracoronary infusion of papaverine].
Mikuniya A; Higashiyama A; Mikami M; Fujino Y; Sasaki N; Sasaki M; Fukushi T; Narita T; Onodera K; Oike Y
J Cardiol; 1992; 22(2-3):549-56. PubMed ID: 1339814
[TBL] [Abstract][Full Text] [Related]
16. Serious ventricular dysrhythmias after intracoronary papaverine.
Wilson RF; White CW
Am J Cardiol; 1988 Dec; 62(17):1301-2. PubMed ID: 2461650
[No Abstract] [Full Text] [Related]
17. Polymorphous ventricular tachycardia after intracoronary papaverine: a report of 3 cases.
Zhang X; Shen W; Cai X; Zheng A
Chin Med Sci J; 1993 Dec; 8(4):248-9. PubMed ID: 8032075
[TBL] [Abstract][Full Text] [Related]
18. Relationship between the degree of coronary artery disease and of left ventricular function and the duration of the QT-interval in ECG.
Krämer B; Brill M; Brühn A; Kübler W
Eur Heart J; 1986 Jan; 7(1):14-24. PubMed ID: 3956520
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of coronary flow reserve using myocardial contrast echocardiography in humans.
Reisner SA; Ong LS; Fitzpatrick PG; Lichtenberg GS; Sullebarger JT; Allen MN; Meltzer RS
Eur Heart J; 1992 Mar; 13(3):389-94. PubMed ID: 1597227
[TBL] [Abstract][Full Text] [Related]
20. [Use of a Soviet-made device for recording late ventricular potentials].
Akasheva DU; Shevchenko NM; Smetnev AS; Kovtun VV; Matlashov AN; Shafigulin FI
Kardiologiia; 1991 Dec; 31(12):71-4. PubMed ID: 1726180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
